The heterogeneity analysis of hepatocellular carcinoma and combined hepatocellular cholangiocarcinoma
RNA-seq (gene expression) · human · 81 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Topic
- CholangiocarcinomaThis series is part of our curated briefing on it.
- Samples
- 81 samples: 29 × A19 vs 28 × A20 vs 24 × A21Groups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE231854_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA968157 and SRA study SRP436315. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 81 samples.
How we read this: 3 replicated groups read from 81 sample titles; they account for 81 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM7305137 A19_268 A19
- GSM7305138 A19_293 A19
- GSM7305139 A19_301 A19
- GSM7305140 A19_390 A19
- GSM7305141 A19_437 A19
- GSM7305142 A19_457 A19
- GSM7305143 A19_480 A19
- GSM7305144 A19_585 A19
- GSM7305145 A19_596 A19
- GSM7305146 A19_605 A19
- GSM7305147 A19_639 A19
- GSM7305148 A19_660 A19
- GSM7305149 A19_673 A19
- GSM7305150 A19_685 A19
- GSM7305151 A19_691 A19
- GSM7305152 A19_695 A19
- GSM7305153 A19_742 A19
- GSM7305154 A19_770 A19
- GSM7305155 A19_772 A19
- GSM7305156 A19_792 A19
- GSM7305157 A19_821 A19
- GSM7305158 A19_826 A19
- GSM7305159 A19_827 A19
- GSM7305160 A19_845 A19
- GSM7305161 A19_860 A19
- GSM7305162 A19_866 A19
- GSM7305163 A19_913 A19
- GSM7305164 A19_916 A19
- GSM7305165 A19_932 A19
- GSM7305166 A20_43 A20
- GSM7305167 A20_68 A20
- GSM7305168 A20_97 A20
- GSM7305169 A20_123 A20
- GSM7305170 A20_137 A20
- GSM7305171 A20_164 A20
- GSM7305172 A20_169 A20
- GSM7305173 A20_175 A20
- GSM7305174 A20_193 A20
- GSM7305175 A20_215 A20
- GSM7305176 A20_250 A20
+ 41 more — browse all 81 samples with per-sample file links →
- GSE290614 Comprehensive Molecular Profiling of Combined Hepatocellular Carcinoma and Cholangiocarcinoma reveals Distinct Notch Signaling Subgroups with Prognostic Significance 18 samples same disease briefing · shares cholangiocarcinoma, hepatocellular, combined
- GSE317889 Combined DNA and RNA profiling refines prognostic stratification independent of therapeutic actionability in cholangiocarcinoma 62 samples same disease briefing · shares cholangiocarcinoma, combined
- GSE274024 NOX4/NOX1 dual inhibition in cholangiocarcinoma as an effective approach to target TGF-beta protumorigenic actions in cancer associated fibroblasts 45 samples same disease briefing · shares cholangiocarcinoma
- GSE318391 Anticancer activity of RAS-GTP inhibition in cholangiocarcinoma 39 samples same disease briefing · shares cholangiocarcinoma
- GSE320081 Molecular and cellular consequences of tumor-autonomous IL-6 signaling in intrahepatic cholangiocarcinoma 36 samples same disease briefing · shares cholangiocarcinoma
- GSE241735 FGFR inhibition blocks NF-ĸB-dependent glucose metabolism and confers metabolic vulnerabilities in cholangiocarcinoma 30 samples same disease briefing · shares cholangiocarcinoma
- GSE235891 Identification of RNF213 as a potential suppressor of local invasion in intrahepatic cholangiocarcinoma 18 samples same disease briefing · shares cholangiocarcinoma
- GSE316441 Transcriptomic profiling of epigenetic regulators and metabolic reprogramming in human cholangiocarcinoma 18 samples same disease briefing · shares cholangiocarcinoma
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.